Journal of Pharmaceutical and Biomedical Sciences

Optimum Initiating Pressure of Nasal CPAP in Newborns with Moderate Respiratory Distress: A Randomised Controlled Trial

Renu Agarwal, Rita Hajela, GS Kochhar, Naveen Jain

Abstract


Objective To decide the optimum initiating pressure of nasal CPAP in newborns with respiratory distress.

Methods The study was done in neonatal intensive care unit (NICU) between November 2009 and November 2011 as a prospective randomised trial in 50 newborns with respiratory distress with Silverman Anderson score of 4–6, excluding babies with major congenital malformation, severe cardiovascular instability and frequent apnea at birth or requiring surfactant at birth. Alternate newborn enrolled was put on nasal CPAP with PEEP of 5 cm of water and FiO2 of 50% or PEEP of 7 cm of water and FiO2 of 50%. Clinical and investigative monitoring was done with X-ray chest on admission to confirm indication and repeated at 3–5 h to check lung expansion and rule out any contraindication or complication. USG Skull was done between 3–5 days to rule out intracranial hemorrhage.

Results Twenty-five babies in each group were put on nasal CPAP with starting FiO2 of 50% and PEEP of 5 cm of water in one group and FiO2 of 50% and PEEP of 7 cm of water in other group. No statistically significant difference was found between various characteristics of both groups like sex, mode of delivery, gestation and birth weight etc. All the patients survived in each group and there was no statistically significant difference between the outcomes of each group. Two patients on initial PEEP of 5 cm group failed on CPAP and three patients on PEEP 7 group failed and had to be shifted on mechanical ventilation.

Conclusions There is no difference in outcome of patients with initial PEEP of 5 cm of water or 7 cm of water. We should initiate CPAP on PEEP of 5 cm, as there is no benefit of starting at a higher PEEP of 7 cm of water; although we got a range of initiating pressure from 5 to 7 cm which is safe in newborns with respiratory distress.


Full Text:

References


NNF recommended basic perinatal, neonatal nomenclatureprinciples and practice. 1st ed. New Delhi: Jaypee Brothers; 1998. pp. 131–132.

Dreyfus D, Saumon G. Ventilator induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med. 1998; 157:294–323.

Hall RT, Rhodes PG. Pneumothorax and pneumomediastinum in infants with idiopathic respiratory distress syndrome receiving CPAP. Paediatrics. 1975;55(4):493–496.

Saunders RA, Milner AD, Holphin IE. The effects of continuous positive airway pressure on lung mechanics and lung volumes in the neonate. Biol Neonate. 1976;29:178–186.

Tanswell AK. Continuous distending pressure in the respiratory distress syndrome of the newborn: who, when, and why? Respir Care. 1982;27(3):257–266.

Tanswell AK, Clubb RA, Smith BT, Boston RW. Individualised continuous distending pressure applied within 6 hours of delivery in infants with respiratory distress syndrome. J Trop Pediatr. 2000;46(3):172–175.

Elgellab A, Riou Y, Abbazine A, et al. Effects of nasal continuous positive airway pressure (NCPAP) on breathing pattern in spontaneously breathing premature newborn infants. Intensive Care Med. 2001;27:1782–1787.

Kumar A, Bhat BV. Epidemiology of respiratory distress of newborn. Indian J Pediatr. 1996;63:93–98.

Report of National Neonatology perinatal database. National Neonatology Forum, India, 2000.

Cotton RB, Lindstrom DP, Kanarek KS, Sundell H, Stalhman MT. Effect of positive end expiratory pressure on right ventricular output in lambs with hyaline membrane disease. Acta Paediatrica Scandinavica. 1980;69(5):603–606.

Miller MJ, Carlo WA, Martin RJ. Continuous positive airway pressure selectively reduces obstructive apnea in preterm infants. J Pediatr. 1985;106:91–94.

Poets CF, Sen B. Changes in intubation rates and outcome of VLBW a population based study. Pediatrics. 1996;98:24–27.

Gitterman MK, Fusch C, Gitterman AR, Regazzoni BM, Moessinger AC. Early nasal continuous positive airway pressure treatment reduces need for intubation in very low birth infants. Eur J Pediatr. 1997;156:384–388.

Miller MJ, DiFiore JM, Strohl KP, Martin RJ. Effects of nasal CPAP on supraglottic and total pulmonary resistance in preterm infants. J App Physiol. 1990;56:141–146.

Gregory GA, Norwalk CT. Continuous Positive Airway Pressure. Neonatal Pulmonary Care, 2nd ed. Norwalk, CT Appleton and Lang; 1986. p. 355.

Halamek LP, Morley C. Continuous positive airway pressure during neonatal resuscitation. Clin Perinatol. 2006;33:83–98.

Yu VYH, Liew SW, Robertson NRC. Pneumothorax in the newborn: changing pattern. Arch Dis Child. 1975;50(6):449–453.

Sankar MJ, Sankar J, Agrawal R, Paul VK, Deorari AK. Proptocol for administering CPAP in neonates. Indian J Pediatr. 2008;75(5):471–478.

Morley CJ, Davis PG. Continuous positive airway pressure: scientific and clinical rationale. Curr Opin Pediatr. 2008;20:119–124.

De Paoli AG, Davis PG, Faber B, et al. Devises and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in pre term neonates. Cochrane Database Syst Rev. 2002;3:CD002977.

Jeena P, Pillay P, Adhikari M. Nasal CPAP in newborns with acute respiratory failure. Ann Trop Paediatr. 2002;22(30):201–207.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.